A Reproducible Porcine ePTFE Arterial Bypass Model for Neointimal Hyperplasia

Journal of Surgical Research

Volumn 148, Issue 2, 2008, Pages 230-237

  Kapadia, Muneera R ^a   Aalami, Oliver O ^a   Najjar, Samer F ^a   Jiang, Qun ^a   Murar, Jozef ^a   Lyle, Brian ^a   Eng, Jason W ^a   Kane, Bonnie ^a   Carroll, Timothy ^a   Cahill, Patricia M ^a   Kibbe, Melina R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

bypass; ePTFE; neointimal hyperplasia; peripheral arterial disease; porcine; restenosis

Indexed keywords

HEPARIN; POLITEF;

ANIMAL TISSUE; ARTERY BYPASS; ARTICLE; ECHOGRAPHY; GRAFT PATENCY; HYPERPLASIA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MORPHOMETRICS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SWINE;

ANIMALS; BLOOD VESSEL PROSTHESIS; CAROTID ARTERIES; DISEASE MODELS, ANIMAL; HYPERPLASIA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; POLYTETRAFLUOROETHYLENE; SWINE; TUNICA INTIMA; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR SURGICAL PROCEDURES;

EID: 46249124835     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.08.003     Document Type: Article

References (24)

1. Clowes A.W., Reidy M.A., and Clowes M.M. Mechanisms of stenosis after arterial injury. Lab Invest 49 (1983) 208
2. Clowes A.W., Reidy M.A., and Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49 (1983) 327
3. Fingerle J., Johnson R., Clowes A.W., et al. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci USA 86 (1989) 8412
4. Davies M.G., and Hagen P.O. Pathobiology of intimal hyperplasia. Br J Surg 81 (1994) 1254
5. Veith F.J., Gupta S.K., Ascer E., et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3 (1986) 104
6. Stonebridge P.A., Prescott R.J., and Ruckley C.V. Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosis. The Joint Vascular Research Group. J Vasc Surg 26 (1997) 543
7. Berger K., Wood S.J., Sauvage L.R., et al. Healing of arterial prostheses in man-its incompleteness. Ann Surg 175 (1972) 118
8. Abbott W.M., Megerman J., Hasson J.E., et al. Effect of compliance mismatch on vascular graft patency. J Vascular Surg 5 (1987) 376
9. Ferrell M., Fuster V., Gold H.K., et al. A dilemma for the 1990s-choosing appropriate experimental animal model for the prevention of restenosis. Circulation 85 (1992) 1630
10. Morishita R., Gibbons G.H., Horiuchi M., et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA 92 (1995) 5855
11. Ehsan A., Mann M.J., Dell'Acqua G., et al. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. J Thorac Cardiovasc Surg 121 (2001) 714
12. Mann M.J., Whittemore A.D., Donaldson M.C., et al. Ex vivo gene therapy of human vascular bypass grafts with E2F decoy: The PREVENT single-center, randomized, controlled trial. Lancet 354 (1999) 1493
13. Conte M.S., Bandyk D.F., Clowes A.W., et al. Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006) 742
14. Alexander J.H., Hafley G., Harrington R., et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery-PREVENT IV: A randomized controlled trial. JAMA 294 (2005) 2446
15. Mason R.G., and Read M.S. Some species differences in fibrinolysis and blood coagulation. J Biomed Mater Res 5 (1971) 121
16. Schwartz R.S., Edwards W.D., Bailey K.R., et al. Differential neointimal response to coronary-artery injury in pigs and dogs-implications for restenosis models. Arterioscler Thromb 14 (1994) 395
17. Edwards N.M., Claridge J.A., Shell D.H., et al. The effect of bacterial contamination on neointimal hyperplasia in vascular grafts. Am Surg 72 (2006) 1168
18. Cikirikcioglu M., Sedelnikov N., Cruz S.O.D., et al. Improved neo-endothelialization of small diameter ePTFE grafts with titanium coating. Int J Artif Organs 29 (2006) 990-999
19. Mellander S., Fogelstrand P., Enocson K., et al. Healing of PTFE grafts in a pig model recruit neointimal cells from different sources and do not endothelialize. Eur J Vasc Endovasc Surg 30 (2005) 63
20. Johnson M.S., McLennan G., Lalka S.G., et al. The porcine hemodialysis access model. J Vasc Intervent Radiol 12 (2001) 969
21. Rotmans J.I., Velema E., Verhagen H.J.M., et al. Rapid, arteriovenous graft failure due to intimal hyperplasia: A porcine bilateral carotid arteriovenous graft model. J Surg Res 113 (2003) 161
22. Cagiannos C., bul-Khoudoud O.R., DeRijk W., et al. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model. J Vasc Surg 42 (2005) 980
23. Kibbe M.R., Tzeng E., Gleixner S.L., et al. Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. J Vasc Surg 34 (2001) 156
24. Haruguchi H., and Teraoka S. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: A review. J Artif Organs 6 (2003) 227